SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001683168-19-000840
Filing Date
2019-03-29
Accepted
2019-03-29 17:03:34
Documents
73
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT xenetic_10k-123118.htm 10-K 1063948
2 SUBSIDIARIES OF REGISTRANT xenetic_10k-ex2101.htm EX-21.1 2461
3 INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM S CONSENT xenetic_10k-ex2301.htm EX-23.1 1967
4 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER xenetic_10k-ex3101.htm EX-31.1 9901
5 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER xenetic_10k-ex3102.htm EX-31.2 9937
6 CERTIFICATION xenetic_10k-ex3201.htm EX-32.1 4396
  Complete submission text file 0001683168-19-000840.txt   4290613

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE xbio-20181231.xml EX-101.INS 619807
8 XBRL SCHEMA FILE xbio-20181231.xsd EX-101.SCH 38282
9 XBRL CALCULATION FILE xbio-20181231_cal.xml EX-101.CAL 52076
10 XBRL DEFINITION FILE xbio-20181231_def.xml EX-101.DEF 234216
11 XBRL LABEL FILE xbio-20181231_lab.xml EX-101.LAB 308862
12 XBRL PRESENTATION FILE xbio-20181231_pre.xml EX-101.PRE 299476
Mailing Address 99 HAYDEN AVENUE, SUITE 230 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE, SUITE 230 LEXINGTON MA 02421 781-778-7720
Xenetic Biosciences, Inc. (Filer) CIK: 0001534525 (see all company filings)

IRS No.: 452952962 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37937 | Film No.: 19717473
SIC: 2834 Pharmaceutical Preparations